市場調查報告書 - 119574

全球的體外照射療法市場:2010年

Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY

出版商 Life Science Intelligence, Inc.
出版日期 2011年05月01日 內容資訊 英文
價格
全球的體外照射療法市場:2010年 Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
出版日期: 2011年05月01日 內容資訊: 英文
簡介

本報告書內容包括:全球的體外照射療法市場的相關整體市場整合解決方案。高品質且詳細的最新資料及每6個月定期更新的最新資料等提供。

第1章 既存的技術和特徴和新興技術

  • 既存技術的特徴
  • 既存技術的課題
    • 適合性
    • 無酸素組織
      • 經濟的要因
        • 補助和國家的政策及計畫
        • 系統價格和相關費用
        • 全球經濟

第2章 美國的體外照射療法市場

  • 市場預測:2007∼2013年
  • 供應商佔有率:2008年
  • 線形加速器及伽碼射線設備市場的影響因素
  • 美國的體外照射療法:線形加速器及伽碼射線設備:2007∼2013年
  • 美國的線形加速器及伽碼射線設備佔有率:2008年
  • 美國的各種系統市場預測:2007∼2013年
  • 線形加速器及伽碼射線設備:2008年及2013年
  • 不景氣的影響:線形加速器及伽碼射線設備
  • 體外照射療法和SRS市場:2007∼2013年
  • 體外照射療法和SRS市場的影響因素:2007∼2013年
  • 各種用途市場預測:2007∼2013年
  • SRS及體外照射療法設備:2008年及2013年
  • 不景氣的影響:SRS設備
  • 定位性放射線治療:美國患者人數:2007∼2013年
  • 定位性放射線治療:美國各種類患者趨勢:2007∼2013年
  • 頭蓋外定位性放射線治療:美國患者人數:2007∼2013年
  • 定位性放射線治療:美國的處理件數:2007∼2013年
  • 定位性放射線治療:美國的各種類處理件數:2007∼2013年
  • 不景氣的影響:頭蓋外定位性放射線治療
  • 體外照射療法所治療的乳癌・肺癌・前列腺癌患者數:2007∼2013年
  • 陽子線治療:美國市場預測:2007∼2013年
  • 陽子線治療設備:美國供應商佔有率:2008年
  • 陽子線治療:患者趨勢:2007∼2013年
  • 陽子線治療:美國處理件數:2007∼2013年

第3章 美國以外的體外照射療法市場

第4章 合併・收購・聯盟

第5章 新興企業

目錄

Table of Contents

1. ESTABLISHED AND EMERGING TECHNOLOGIES

  • 1.1. Features of Established Technologies
  • 1.2. Challenges for Established Technologies
    • 1.2.1. Conformality
    • 1.2.2. Anoxic Tissues
      • 1.2.2.1. Economic Factors
        • 1.2.2.1.1. Reimbursement and National Policies and Initiatives
        • 1.2.2.1.2. System Prices & Associated Costs
        • 1.2.2.1.3. The Global Economy
  • Exhibit 1-1: External Radiation Therapy by Type
  • Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
  • Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
  • Exhibit 1-4: Features of Particle Therapy Centers
  • Exhibit 1-5: Challenges Associated with Available Technologies
  • Exhibit 1-6: Established and Emerging Technologies

2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators & Gamma-Ray Systems, 2007-2013
  • Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
  • Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
  • Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear Accelerators, 2007-2013
  • Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by Application, 2007-2013
  • Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
  • Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
  • Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type, 2007-2013
  • Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type, 2007-2013
  • Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type, 2007-2013
  • Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure, 2007-2013
  • Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems, 2007-2013.
  • Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
  • Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External Radiation Therapy in the U.S., 2007-2013
  • Exhibit 2-24: Other Patients Treated with External Radiation Therapy, 2007-2013
  • Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S., 2007-2013
  • Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy, 2007-2013
  • Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
  • Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
  • Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013

3. OUS MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 3-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
  • Exhibit 3-2: OUS External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 3-3: Factors Influencing the OUS Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 3-4: External Radiation Therapy in Europe, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-5: Linear Accelerator & Gamma-Ray Systems, European Shares in 2008
  • Exhibit 3-6: European Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 3-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 & 2013
  • Exhibit 3-8: AP & ROW External Radiation Therapy, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
  • Exhibit 3-10: AP & ROW Market Forecast by Type of System, Gamma-Ray & Linear Accelerator Systems, 2007-2013
  • Exhibit 3-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
  • Exhibit 3-12: Factors Influencing the OUS Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 3-13: External Radiation Therapy, European Market Forecast by Application, 2007-2013
  • Exhibit 3-14: SRS and External Radiation Systems in Europe, 2008 & 2013
  • Exhibit 3-15: Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-16: Stereotactic Radiosurgery - European Patient Volumes by Type, 2007-2013
  • Exhibit 3-17: Stereotactic Radiosurgery - Utilization by Patient Type in Europe, 2007-2013
  • Exhibit 3-18: Extracranial Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-19: Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-20: Stereotactic Radiosurgery - European Procedures by Type, 2007-2013
  • Exhibit 3-21: Stereotactic Radiosurgery in Europe - Utilization by Procedure, 2007-2013
  • Exhibit 3-22: Extracranial Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-23: Breast, Lung and Prostate Patients Treated with Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-24: Other Patients Treated with External Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-25: External Radiation Therapy in Europe, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-26: Other External Radiation Therapy Procedures in Europe, 2007-2013
  • Exhibit 3-27: External Radiation Therapy, AP & ROW Market Forecast by Application, 2007-2013
  • Exhibit 3-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes, 2007-2013
  • Exhibit 3-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by Type, 2007-2013
  • Exhibit 3-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of Patients, 2007-2013
  • Exhibit 3-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes, 2007-2013
  • Exhibit 3-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type, 2007-2013
  • Exhibit 3-33: Breast, Lung and Prostate Patients Treated with Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-34: Other Patients Treated with External Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-35: External Radiation Therapy in AP & ROW Countries, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-36: Other External Radiation Therapy Procedures in AP & ROW Countries, 2007-2013
  • Exhibit 3-37: Factors Influencing the OUS Market for Particle Therapy, 2007-2013
  • Exhibit 3-38: Particle Therapy, European Market Forecast, 2007-2013
  • Exhibit 3-39: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-40: Particle Therapy Systems, European Supplier Shares in 2008
  • Exhibit 3-41: Particle Therapy, European Patient Volumes, 2007-2013
  • Exhibit 3-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
  • Exhibit 3-43: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
  • Exhibit 3-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013

4. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

5. EMERGING COMPANIES

全球的體外照射療法市場:2010年是由出版商Life Science Intelligence, Inc.在2011年05月01日所出版的。這份市場調查報告書價格從美金6500起跳。

Back to Top
;